eWave Patch for Heart Monitoring
What You Need to Know Before You Apply
What is the purpose of this trial?
This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.
Who Is on the Research Team?
Chris Daniel
Principal Investigator
WearLinq, Inc.
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive and apply the WearLinq patch for 7 consecutive days
Extended Use
A subset of participants will continue to use the WearLinq patch for 30 consecutive days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- eWave Patch
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants will receive and apply the WearLinq patch for 30 consecutive days
Participants will receive and apply the WearLinq patch for 7 consecutive days
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wearlinq
Lead Sponsor
ABio Clinical Research Partners
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.